BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8204887)

  • 1. BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy.
    Guo JQ; Lian JY; Xian YM; Lee MS; Deisseroth AB; Stass SA; Champlin RE; Talpaz M; Wang JY; Arlinghaus RB
    Blood; 1994 Jun; 83(12):3629-37. PubMed ID: 8204887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.
    Guo JQ; Wang JY; Arlinghaus RB
    Cancer Res; 1991 Jun; 51(11):3048-51. PubMed ID: 2032243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients.
    Guo JQ; Lian J; Glassman A; Talpaz M; Kantarjian H; Deisseroth AB; Arlinghaus RB
    Am J Clin Pathol; 1996 Oct; 106(4):442-8. PubMed ID: 8853030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia.
    Hessner MJ; Roth MS; Drobyski WR; Baxter-Lowe LA
    Genet Anal Tech Appl; 1994; 11(4):90-4. PubMed ID: 7857690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
    Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
    Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
    J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL rearrangements in children with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Aurer I; Butturini A; Gale RP
    Blood; 1991 Nov; 78(9):2407-10. PubMed ID: 1932752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patients.
    Schleuning M; Mittermüller J; Kolb HJ
    Eur J Haematol; 1999 Mar; 62(3):149-54. PubMed ID: 10089891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia.
    Jonas D; Lübbert M; Kawasaki ES; Henke M; Bross KJ; Mertelsmann R; Herrmann F
    Blood; 1992 Feb; 79(4):1017-23. PubMed ID: 1371078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crises.
    Ponzetto C; Guerrasio A; Rosso C; Avanzi G; Tassinari A; Zaccaria A; LoCoco F; Foa R; Basso G; Abate ML
    Br J Haematol; 1990 Sep; 76(1):39-44. PubMed ID: 2223647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Inoue T; Tojo A; Futaki M; Miyake K; Yamada T; Tanabe Y; Ohki I; Dan K; Ozawa K
    Blood; 1991 Dec; 78(12):3125-7. PubMed ID: 1742479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
    Wells SJ; Phillips CN; Winton EF; Farhi DC
    Am J Clin Pathol; 1996 Jun; 105(6):756-60. PubMed ID: 8659451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of childhood chronic myelogenous leukemia with monitoring the BCR-ABL fusion gene expression in peripheral blood.
    Horváth A; Baghiu MD; Pap Z; Bănescu C; Mărginean CO; Pávai Z
    Rom J Morphol Embryol; 2011; 52(3):907-13. PubMed ID: 21892537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon.
    Oka T; Sastry KJ; Nehete P; Schapiro SJ; Guo JQ; Talpaz M; Arlinghaus RB
    Leukemia; 1998 Feb; 12(2):155-63. PubMed ID: 9519777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p185(BCR/ABL) has a lower sensitivity than p210(BCR/ABL) to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia.
    Mian AA; Metodieva A; Najajreh Y; Ottmann OG; Mahajna J; Ruthardt M
    Haematologica; 2012 Feb; 97(2):251-7. PubMed ID: 22058195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.